MedTrace Logo

Chemotherapy-Induced Peripheral Neuropathy-Essential Oil Intervention

NCT03449303 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2020-11-02

No results posted yet for this study

Summary

This study will evaluate an oil blend with active ingredients for the reduction in chemotherapy-induced peripheral neuropathy in people with breast cancer. Half of the participants will receive the oil blend with active ingredients and the other half will receive a placebo (an oil blend with no active ingredients). One-fourth of the people will also take pictures of their life with chemotherapy-induced peripheral neuropathy.

Conditions

Interventions

OTHER

EOI

Topically-applied oil

OTHER

Placebo

Topically-applied oil

Sponsors & Collaborators

  • American Holistic Nurses Association

    collaborator UNKNOWN

  • American Nurses Foundation

    collaborator OTHER

  • Ananda Apothecary

    collaborator UNKNOWN

  • The Jojoba Company

    collaborator UNKNOWN

  • Augusta University

    lead OTHER

Principal Investigators

  • Julie K Zadinsky, PhD · Augusta University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-25
Primary Completion
2019-12-30
Completion
2019-12-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03449303 on ClinicalTrials.gov